Clinical experience with glipizide in the treatment of mostly complicated diabetes.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D003510:Cyclohexanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006029:Glycosuria; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D008055:Lipids; D011719:Pyrazines; D013453:Sulfonylurea Compounds